These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15588759

  • 1. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ, Shireen E, Haleem MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [Abstract] [Full Text] [Related]

  • 2. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ, Samad N, Haleem MA.
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [Abstract] [Full Text] [Related]

  • 3. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens.
    Ohno Y, Shimizu S, Imaki J, Ishihara S, Sofue N, Sasa M, Kawai Y.
    Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397
    [Abstract] [Full Text] [Related]

  • 4. Increase in the effectiveness of somatodendritic 5-HT-1A receptors in a rat model of tardive dyskinesia.
    Samad N, Khan A, Perveen T, Haider S, Abdul Haleem M, Haleem DJ.
    Acta Neurobiol Exp (Wars); 2007 Oct; 67(4):389-97. PubMed ID: 18320717
    [Abstract] [Full Text] [Related]

  • 5. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F, Haleem DJ.
    Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
    Haleem DJ, Khan NH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol.
    Shireen E, Qurrat-ul-Ain, Batool F, Saify ZS, Haleem DJ.
    Pak J Pharm Sci; 2002 Jan; 15(1):71-82. PubMed ID: 16414870
    [Abstract] [Full Text] [Related]

  • 8. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
    Mignon L, Wolf WA.
    Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
    [Abstract] [Full Text] [Related]

  • 9. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
    Khan A, Haleem DJ.
    Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
    [Abstract] [Full Text] [Related]

  • 10. Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders.
    Shimizu S, Tatara A, Imaki J, Ohno Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug 16; 34(6):877-81. PubMed ID: 20398719
    [Abstract] [Full Text] [Related]

  • 11. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 12. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 12; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 13. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N, Matsuda T, Koushi E, Mishima K, Iwasaki K, Shoyama Y, Fujiwara M.
    Eur J Pharmacol; 2006 Nov 21; 550(1-3):117-22. PubMed ID: 17022969
    [Abstract] [Full Text] [Related]

  • 14. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S, Chiang TJ, Mobini S, Ho MY, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2001 Nov 21; 158(3):305-13. PubMed ID: 11713621
    [Abstract] [Full Text] [Related]

  • 15. Role of serotonin-1A receptors in restraint-induced behavioral deficits and adaptation to repeated restraint stress in rats.
    Haleem DJ, Samad N, Perveen T, Haider S, Haleem MA.
    Int J Neurosci; 2007 Feb 21; 117(2):243-57. PubMed ID: 17365111
    [Abstract] [Full Text] [Related]

  • 16. Desensitization of pre and post synaptic 5-HT-1A receptor responses following long term consumption of sugar rich diet: implications for sugar-induced obesity.
    Jabeen B, Haleem DJ.
    Pak J Pharm Sci; 2008 Oct 21; 21(4):327-32. PubMed ID: 18930850
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul 21; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 18. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB, Ravailhe V, Faucillon V, Newman-Tancredi A.
    J Pharmacol Exp Ther; 2005 Oct 21; 315(1):265-72. PubMed ID: 15987834
    [Abstract] [Full Text] [Related]

  • 19. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 20. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
    Bubeníková-Valesová V, Votava M, Pálenícek T, Horácek J.
    Neuropharmacology; 2007 Mar 10; 52(4):1071-8. PubMed ID: 17196227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.